Additionally, EphA3-targeted chimeric antigen receptor (CAR)-T cells demonstrated robust antigen-specific killing of human glioblastoma and diffuse midline glioma cell lines in animal models [27,28]. Here, EPHA3 is linked to glioblastoma.